Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Most patients start to experience these treatment benefits during the initial weeks of their therapy
The peptide is primarily researched for stimulation of lipolysis and inhibition of lipogenesis , while also demonstrating activity in glucose regulation pathways without activating growth hormonerelated signaling cascades
AOD-9604 will not overcome a caloric surplus
FDA reportedly granted GRAS status for one specific oral formulation but not for the injectable peptide
The recommended dietary allowance (RDA) for most adults is 2.4 mcg per day, though some may need more based on specific health considerations
